Apellis Pharmaceuticals (APLS) has a market capitalization of $3.2B, based on 126.29M shares at a price of $25.12 (down 3.3% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $25.12 | 19,398,511 | 126,289,916 | $3,172,402,689.92 |
September 2025 | $22.63 | 47,886,083 | 126,000,000 | $2,851,380,000.00 |
August 2025 | $27.57 | 50,204,446 | 126,000,000 | $3,473,820,000.00 |
July 2025 | $22.34 | 56,637,162 | 126,000,000 | $2,814,840,000.00 |
June 2025 | $17.31 | 41,675,661 | 126,000,000 | $2,181,060,000.00 |
May 2025 | $16.93 | 62,805,251 | 126,000,000 | $2,133,180,000.00 |
April 2025 | $19.21 | 57,195,796 | 126,000,000 | $2,420,460,000.00 |
March 2025 | $21.87 | 38,839,194 | 125,000,000 | $2,733,750,000.00 |
February 2025 | $25.15 | 30,472,376 | 125,000,000 | $3,143,750,000.00 |
January 2025 | $29.01 | 39,447,885 | 125,000,000 | $3,626,250,000.00 |
December 2024 | $31.91 | 54,746,100 | 124,000,000 | $3,956,840,000.00 |
November 2024 | $33.93 | 90,934,848 | 124,000,000 | $4,207,320,000.00 |
October 2024 | $27.26 | 67,683,267 | 124,000,000 | $3,380,240,000.00 |
September 2024 | $28.84 | 38,412,742 | 124,000,000 | $3,576,160,000.00 |
August 2024 | $38.90 | 33,158,715 | 124,000,000 | $4,823,600,000.00 |
July 2024 | $39.60 | 30,253,086 | 124,000,000 | $4,910,400,000.00 |
June 2024 | $38.36 | 25,244,681 | 124,000,000 | $4,756,640,000.00 |
May 2024 | $39.25 | 33,500,103 | 124,000,000 | $4,867,000,000.00 |
April 2024 | $44.19 | 32,216,063 | 124,000,000 | $5,479,560,000.00 |
March 2024 | $58.78 | 25,594,260 | 123,000,000 | $7,229,940,000.00 |
February 2024 | $61.97 | 29,700,518 | 123,000,000 | $7,622,310,000.00 |
January 2024 | $63.29 | 40,118,729 | 123,000,000 | $7,784,670,000.00 |
December 2023 | $59.86 | 59,974,233 | 119,000,000 | $7,123,340,000.00 |
November 2023 | $53.87 | 38,829,962 | 119,000,000 | $6,410,530,000.00 |
October 2023 | $48.66 | 50,099,353 | 119,000,000 | $5,790,540,000.00 |
